“…Established treatment for K. Kingae endocarditis consists of a high dose intravenous β-lactam antimicrobial as monotherapy or combined with an aminoglycoside drug for 4–7 weeks duration [6]. Despite K. kingae ’s remarkable susceptibility to antimicrobial drugs, serious complications such as mycotic aneurisms, pericarditis, valvular insufficiency, congestive heart failure, CVAs, embolic arthritis and cellulitis are common complications [1,6]. …”